Home Forums Melanoma Diagnosis: Stage IV BMS PD1 Trial possibly recruiting Reply To: BMS PD1 Trial possibly recruiting

#63243
Catherine Poole
Keymaster

I’m reading this as: Prior therapy with an immune cell modulating antibody except for anti-Cytotoxic T Lymphocyte Antigen 4 (CTLA4)

The exception being IPI, so it does allow IPI. I know the writing is terribly confusing in these trials.